James W. Williams

High Impact

Assistant Professor

UAMS

Last publication 2025 Last refreshed 2026-05-16

faculty

COM | Peds Critical Care

44 h-index 186 pubs 8,654 cited

Research Areas

Links

ORCID Lab Website Research Group UAMS TRI Profile

OverviewAI-generated summary

James W. Williams' research focuses on various aspects of health sciences, with recent publications addressing topics such as the use of pembrolizumab in uterine leiomyosarcoma, the safety and efficacy of fampridine for multiple sclerosis, and outcomes for cats undergoing splenectomy. His work also includes investigations into HPV-associated vulvar intraepithelial neoplasia and the therapeutic potential of peptide-based vaccines for cervical intraepithelial neoplasia. Additionally, Williams has explored patient experiences with cyclic vomiting syndrome and opioid use in patients with cervical cancer.

With a h-index of 42 and over 136 publications attracting more than 6,580 citations, Williams is recognized as a highly cited researcher. He maintains an active research group and collaborates with several colleagues at the University of Arkansas for Medical Sciences, including H. Williams and Maya Williams, with whom he shares 12 co-authored publications.

Metrics

h-index: 44
Publications: 186
Citations: 8,654

Selected Publications

189 Implementing an opioid overdose education and naloxone distribution (OEND) Training-of-Trainers Program in rural pharmacies: Qualitative insights (2026)

DOI OpenAlex
GORE VIABAHN VBX Balloon-Expandable Endoprosthesis in Treatment of Posttransplant Portal Vein Stenosis: A Case Series (2026)

DOI OpenAlex
Methylomic Analysis of Nasal Brushings Reveals Two Subgroups in Pediatric Acute Respiratory Distress Syndrome (2026)

DOI OpenAlex
Regulatory Challenges and Opportunities: A Review of U.S. Food and Drug Administration-Approved Artificial Intelligence and Machine Learning-Enabled Cardiovascular Devices (2025)

2 citations DOI OpenAlex
Evaluating the implementation and sustainment potential of a pharmacy-embedded community health worker model (2025)

DOI OpenAlex
444 scRNA seq analysis of lower respiratory tract immune cells to uncover immuno-endotypes in SA-PARDS (2025)

DOI OpenAlex
A Randomized Double-Blind Phase 2 Clinical Trial Treating Cervical Intraepithelial Neoplasia 2/3 with PepCan or <i>Candida</i> (2025)

2 citations DOI OpenAlex
Factors Contributing to Opioid Overprescribing at Surgical Discharge (2025)

DOI OpenAlex
744P A phase II study of ACR-368 in patients with ovarian (OvCa) or endometrial carcinoma (EnCa) and prospective validation of OncoSignature patient selection (NCT05548296) (2024)

2 citations DOI OpenAlex
891: ENDOTHELIAL BIOMARKERS PREDICT PERSISTENT PEDIATRIC SEPSIS-ASSOCIATED ACUTE RESPIRATORY DYSFUNCTION (2023)

DOI OpenAlex
Rapidly Progressive Respiratory Failure and Shock in a Healthy Teenager (2023)

DOI OpenAlex
Developing a mechanistic understanding of pediatric acute respiratory distress syndrome one cell at a time (2023)

DOI OpenAlex
A peptide-based human papillomavirus therapeutic vaccine, PepCan, or <i>Candida</i> adjuvant alone in treatment of cervical intraepithelial neoplasia 2/3 (CIN2/3). (2023)

2 citations DOI OpenAlex
HPV-associated Vulvar Intraepithelial Carcinoma With Sebaceous Differentiation: Report of 2 Cases (2022)

4 citations DOI OpenAlex

View all publications on OpenAlex →

Grants & Funding

scRNA seq Analysis of Lower Respiratory Tract Immune Cells to Uncover Immuno-Endotypes in Sepsis- Associated Pediatric Acute Respiratory Distress Syndrome UAMS College of Medicine Principal Investigator